title: Is the tiered immunogenicity testing of biologics the adequate approach in preclinical development?
authors.forename: Melody
authors.initials: M
authors.lastname: Sauerborn
mesh_terms: D057134:Antibodies, Neutralizing / Q000276:immunology; D001688:Biological Products / Q000009:adverse effects / Q000032:analysis* / Q000276:immunology*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D055261:Immunogenetic Phenomena
chemical_list: D057134:Antibodies, Neutralizing; D001688:Biological Products